The Deal
Sunday, November 22, 
2:31 am

Nanotechnology investment, products on the rise

  Share     E-Mail    Discussion    Print Story

 

lux.jpgNanotechnology continues to be a somewhat vague term, but Lux Research Tuesday released a new report that seeks to quantify some of the recent investment and product development in the area, concluding that nanotech companies have shifted from discovery to commercialization.

The proof of that conclusion lies in this statistic: Sales from the sector, which hit $50 billion last year, easily oustripped the $11.8 billion invested in this area, the study says. Venture capital investors put $699 million into nanotechnology companies in 2006, up 10% from 2005, the report continues.

Lux notes the maturity of the sector, pointing out that industries ranging from pharmaceuticals to power tools now incorporate nanotechnology, and there are established markets for components such as carbon nanotubes. That particular market grew 87% last year to $49 million.
 
The field also got a boost from the recent surge in solar and other energy and environmental markets that have put a premium on the development of new materials.

And while it seems that the fad of a few years ago to jump on the nanotech bandwagon by renaming existing companies has subsided, the report notes that more new companies with the term "nano" in their names received funding in 2006 than in any prior year. - Clifford Carlsen

See Nov. 20 press release from Lux Research
See October 2006 story from The Deal newsweekly
See September 2006 story from TheDeal.com

Continue reading below

Also on Dealscape





Post a comment




The Deal Pipeline

Deal Video


Inside The Deal: Avaya Inc.'s Mohamad Ali on the company's next target.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Managing your shareholder base

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.


Industry Insight

Easing the stress of distressed M&A

Corporate buyers face numerous complexities when trying to identify the right moment to purchase a distressed asset.


Editor's Note

Editor's letter: Nov. 16, 2009

Beneath the veneer of Wall Streeters beats the same heart, stirred by the same determinants of behavior.



©Copyright 2008, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.